This is a preview of subscription content, log in via an institution to check access.
References
Lee WY, Tzeng C, Jin YT, Chow NH, Yip CM, Lee JCl. Papillary cystic tumor of pancreas: a case indistin-guishable from oncocytic tumor. Pancreas 1993;8:127–132.
Adsay NV, Adair CF, Heffess CS, Heffes CS, Klimstra DS. Intraductal oncocytic papillary neoplasm of the pancreas. Am J Surg Pathol 1996;20:980–994.
Jyotheeswaran S, Zotalis G, Penmetsta P, Levea CM, Schoeniger LO, Shah AN. A newly recognized entity: Intraductal “Oncocytic” papillary neoplasm of the pancreas. Am J Gastroenterol 1998;93:2538–2543.
Maisey NR, Webb A, Flux GD, Padhani A, Cunnigham DC, Ott RJ, Norman A. FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer 2000;83:287–293.
Keogan MT, Tyler D, Clark L, Branch MS, McDermott VG, DeLong DM, Coleman RE. Diagnosis of pancreatic carcinoma: role of FDG PET. Am J Radiol 1998;17:1565–1570.
Franke C, Klapdor R, Meyerhoff K, Schauman M. 18-FDG positron emission tomgraphy of the pancreas: diagnostic benefit in follow-up of pancreas carcinoma. Anticancer Res 1999;19:2437–2442.
Nakamoto Y, Higashi T, Skahara H, Tamaki N, Kogire M, Doi R, et al. Delayed 18F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 2000;89:2547–2554.
Di Chiro G, De La Paz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, et al. Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose positron emission tomography. Neurology 1982;32:1323–1329.
Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlations with glucose metabolism mesured by fluorine-18-fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60:1348–1362.
Nieweg OE, Prium J, van Grinkel RJ, Hoekstra HJ, Paans AMJ, Molenaar MW, et al. Fluoride-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 1996;37:227–261.
Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, et al. Fluorine-18-FDG PET imaging is negative bronchioloaveolar lung carcinoma. J Nucl Med 1998;39:1016–1020.
Wiesner W, Engel H, von Schulthess GK, Krestin GP, Bicik I. FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive Hurthel cell tumor of the thyroid. Eur Radiol 1999;9:975–978.
Soofer SB, Tabbara S. Intraductal papilloma of salivary gland: a report two cases with diagnosis by fine needle aspiration biopsy. Acta Cytlog 1999;43:1142–1146.
Grunwald F, Menzel C, Bender H, et al. Comparison of 18 FDG-PET with 131 iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 1997;7:327–335.
Tallini G, Ladanyi M, Rosai J, Jhanwar C. Analysis of nuclear and mitochondrial DNA alteration in thyroid and renal oncocytic tumor. Cytogenet Cell Genet 1994;66:253–259.
Ebner D, Rodel G, Pavebstaedt I, Haferkamp O. Functional and molecular analysis of mitochondria in thyroid oncocytoma. Virchow Arch B Cell Pathol Incl Mol Pathol 1991;60:139–144.
Kuwahara H, Shimazaki M, Kadoya Y, Mitsuhashi T, Hong SS, Ogawa Y, Yagi T. Immunohistochemical localization of two type of carbonic anhydrase isozymes in oncocytoma and oncocytic epithelial cells. Osaka City Med J 1989;35:121–136.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Noji, T., Kondo, S., Hirano, S. et al. Intraductal oncocytic papillary neoplasm of the pancreas shows strong positivity on FDG-PET. Int J Gastrointest Canc 32, 43–46 (2002). https://doi.org/10.1385/IJGC:32:1:43
Issue Date:
DOI: https://doi.org/10.1385/IJGC:32:1:43